| 000 | 01240 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250511191658.0 | ||
| 264 | 0 | _c19920330 | |
| 008 | 199203s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/0264-410x(92)90029-j _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBriggs, D J | |
| 245 | 0 | 0 |
_aLongevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. _h[electronic resource] |
| 260 |
_bVaccine _c1992 |
||
| 300 |
_a125-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intradermal |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRabies Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aRabies virus _ximmunology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSchwenke, J R | |
| 773 | 0 |
_tVaccine _gvol. 10 _gno. 2 _gp. 125-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0264-410x(92)90029-j _zAvailable from publisher's website |
| 999 |
_c1545948 _d1545948 |
||